Guru Ownership Trend
Guru Analysis for Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. (ALNY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $326.38 M.
Top institutional holders include Cliff Asness and Ray Dalio.
Institutional sentiment is currently Bullish. This is evidenced by a $5.26 M net inflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position. Conversely, Murray Stahl reduced exposure by 4.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Alnylam Pharmaceuticals, Inc. (ALNY)
Major holders include Cliff Asness ($297.87 M), Ray Dalio ($35.27 M), Joel Greenblatt ($14.46 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.1 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.26 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited ALNY. The total reported sell value was $5.03 M.
Yes, 1 managers opened new positions in ALNY, and 2 increased their existing holdings. The total reported buy value was $10.29 M.